Akeso Biopharma
![Akeso's Cadonilimab Shows Promising Survival Outcomes in Severe Gastric Cancer](https://pharmtales.com/wp-content/uploads/2023/11/Akesos-Cadonilimab-Achieves-Significant-Overall-Survival-in-Severe-Gastric-Cancer-Patients.jpg)
Akeso’s Cadonilimab Achieves Significant Overall Survival in Severe Gastric Cancer Patients
Anika Sharma
Akeso’s bispecific antibody has demonstrated a significant improvement in overall survival for first-line patients with severe gastric cancer or gastroesophageal ...